KRAS and non-small cell lung carcinoma: In the present study, we identified that HIF1A-As2 and MYC form a double-regulatory loop that enhances cell survival, tumor growth and metastasis, suggesting targeting HIF1A-As2 could be a vulnerability in KRAS-dependent NSCLC (Fig. 8G).